Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Patients should check with their healthcare provider about local availability
In most cases, the benefits far outweigh the risks, especially when patients are properly screened and supported
Portillo Canales and colleagues tracked 110 men with obesity - many also with type 2 diabetes - who were being treated with semaglutide, dulaglutide or tirzepatide, the active ingredients in Novo Nordisk's Wegovy and Ozempic or Eli Lilly's Trulicity, Mounjaro, and Zepbound
Curious about how compounded semaglutide compares to the standard version
However, this research comes with important caveats: Current studies remain small-scale with significant methodological limitations No GLP-1 medication is currently FDA-approved specifically for treating binge eating disorder The suppression of appetite that may reduce bingeing in some individuals could paradoxically reinforce restriction in others especially if binge-purge cycles are present If you have binge eating disorder and are considering a GLP-1 medication, working with a registered dietitian who specializes in eating disorders before and during treatment is essential not optional
US$ 23.07
US$ 23.73
US$ 28.70
US$ 20.28
US$ 21.93
